The Glucose Never Lies®

Science and lived experience
for type 1 diabetes

An independent education platform that translates complex diabetes science into clear, practical understanding. Built by clinicians and people living with type 1 diabetes, grounded in peer-reviewed evidence, and designed to help you explore how glucose really works.

GRACE20% Human Ingenuity, 80% AI ProficiencyPowered by Barbell AI Systems

How does Grace work?

Ask Grace anything about type 1 diabetes: medical devices, exercise, high-fat and high-protein meals, everyday life. She pulls the research together and answers at the reading level you choose, which you can change as your knowledge grows. For what to do for you or your child, ask your diabetes team; in an emergency, call 999.

Reading level

Answers at your reading level

In Ask Grace, pick how you like to read and she will answer that way; any level is open to anyone, and she starts at Advancing.

  1. Level 1, Easy

    5+ (read with a grown-up)

    Young children and families, newly diagnosed

  2. Level 2, Straightforward

    8+

    Living with diabetes

  3. Level 3, Advancing

    12+

    Experienced users, educators

    Starts here
  4. Level 4, Clinical

    Adult

    Nurses, dietitians, doctors

  5. Level 5, Scientific

    Adult

    Researchers

What you can do

What you can do with Grace

Ask and Explore are open to everyone; Build, Write and Review need an access token.

  • Open: Ask

    About the evidence: a study, a claim, a device. In Ask Grace.

  • Open: Explore

    GNL's educational explorers, from population evidence. Their modelling is GNL's own, so it sits at E on the A to E key: for learning, not for one person's dose. In Tools.

  • Needs a token: Build

    Your own explorers, sites and platforms.

  • Needs a token: Write

    Manuscripts and documents.

  • Needs a token: Review

    Your work checked, so it stays honest.

Grace can help you build your own explorers, sites and platforms, write manuscripts, and review work so it stays honest. These need an access token. Contact john@theglucoseneverlies.com.

Checking evidence

How the evidence is checked

When a paper comes into Grace, it is read closely and asked the same strict questions, in this order.

  1. Question 1: How was the study built?

    Each paper gets one letter for how the study was built, not how strong its advice is. Randomised means chance decides who gets what.

  2. Question 2: What did they measure, and why?

    How directly did the study measure a harm or benefit the person actually has, rather than a stand-in for one?

  3. Question 3: Did they measure it well?

    Was it measured for long enough to see a change? And often enough to see the path, and to know the change held?

  4. Question 4: Were the results read right?

    Did the authors read their own numbers fairly? Or were the results not stated?

  5. Question 5: So what, for people with diabetes?

    A judgement, with its reasons, on how useful the research is to people living with diabetes.

The A to E letter, for how a study was built

  1. AThe strongest randomised trials and reviews
  2. BOther cause-and-effect studies
  3. CReal-world observation
  4. DConsensus and guidelinesA guideline sits at D because the letter records how a source was built, not how strong its advice is.
  5. EUnvalidated, including GNL's own modelling
Grace's foundations

Created by two people with skin in the game

For people living with diabetes. Everything above stands on this.

Grace was developed around the papers supporting the ISPAD, ADA and EASD diabetes guidelines. She is built on around 1,000 of them. From that base, she takes in only papers that add value for people with diabetes, always asking: so what, for people with diabetes?

The Glucose Never Lies began with John's son, who tested positive for type 1 antibodies on a blood spot test. John needed a platform that could teach anyone who looked after his son. Grace draws on his 20 years of expertise, his publications and his skill in putting the evidence into practice at Birmingham Children's Hospital.

Phillip Hayes, John's best mate, is an expert in AI product development at a successful start-up in this field. He knows how to deliver the quality, safety and remarkable flexibility of an AI system, at a cost that keeps Grace free for people with type 1 diabetes.

For more on Grace's architecture, safety guardrails, ingest procedure, and medical and legal compliance, contact john@theglucoseneverlies.com.

The GNL Podcast

Latest episodes.

Episode 43

Tandem Control-IQ+ and Mobi, with Laurel Messer

The AID series opens: correction factor as the lever, what Control-IQ+ changes, and the matchbox sized Tandem Mobi.

Listen to Episode 43
Episode 42

DICE 2026 Highlights

Highlights and key takeaways from the DICE 2026 conference.

Listen to Episode 42
Episode 41

CGM Series Review and the Diabetech Conversation

Closing the CGM series, with a wide-ranging conversation on where diabetes technology is heading.

Listen to Episode 41

Get in touch

Contact and follow.

Enquiries

Email John

Consultancy, speaking, and educational projects.

john@theglucoseneverlies.com
Technology

Email Phill

AI solutions, including the technology that powers Grace.

phill@theglucoseneverlies.com
Follow

YouTube and socials

Watch and follow along across the channels.

YouTube · Instagram · LinkedIn · X